Exact Mass: 423.06556480000006
Exact Mass Matches: 423.06556480000006
Found 103 metabolites which its exact mass value is equals to given mass value 423.06556480000006,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cephapirin
Cephapirin is an injectable, first-generation cephalosporin antibiotic that has a wide spectrum of activity against gram-positive and gram-negative organisms. The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cephapirin is more resistant to beta-lactamases than the penicillins, and therefore is effective against staphylococci, with the exception of methicillin-resistant staphylococci. Cephapirin is FDA approved for use in food-producing animals, especially dairy cattle. Cephapirin is used for the treatment of mastitis in cows. Production for use in humans has been discontinued in the United States. It is marketed under the trade name Cefadyl. Active against gram-positive and -negative bacteria (vet. use). FDA approved for use in food producing animals, especies dairy cattle. It is used for the treatment of mastitis in cows J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Glucoiberin
Glucoiberin belongs to the class of organic compounds known as alkylglucosinolates. These are organic compounds containing a glucosinolate moiety that carries an alkyl chain. Glucoiberin is an extremely weak basic (essentially neutral) compound (based on its pKa). Glucoiberin has been detected, but not quantified in, several different foods, such as capers, cauliflowers, cabbages, Brassicas, and Chinese cabbages. This could make glucoiberin a potential biomarker for the consumption of these foods. Glucoiberin is isolated from the seeds of Brassica oleracea and other crucifers. Isolated from seeds of Brassica oleracea and other crucifers. Glucoiberin is found in many foods, some of which are white cabbage, cabbage, broccoli, and brussel sprouts. Acquisition and generation of the data is financially supported in part by CREST/JST.
Gluconasturtiin
Isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Gluconasturtiin is found in many foods, some of which are radish, broccoli, watercress, and brassicas. Gluconasturtiin is found in brassicas. Gluconasturtiin is isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Acquisition and generation of the data is financially supported in part by CREST/JST.
Xanthommatin
An ommochrome that consists of a pyrido[3,2-a]phenoxazine ring system bearing hydroxy, carboxy, oxo and 3-amino-3-carboxypropanoyl substituents at positions 1, 3, 5 and 11 respectively. The parent of the class of xanthommatins.
Calicheamicinone
C18H17NO5S3 (423.02688320000004)
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 4-methylsulfinyl-N-sulfooxy-butanimidothioate
5-Amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonic acid
5-Amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonic acid is a food dye.
N-(4-Sulfophenyl)adenosine
Pradefovir
C17H19ClN5O4P (423.08631340000005)
S-(1,2-Dicarboxyethyl)glutathione
C14H21N3O10S (423.09476060000003)
Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate
C21H17N3O3S2 (423.07112920000003)
Gluconasturtiin
An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-phenyl-N-(sulfooxy)propanimidoyl group at the anomeric sulfur.
CAY10535
C18H21N3O7S (423.11001560000005)
Glucosinalbate
Glucoiberin
Acquisition and generation of the data is financially supported by the Max-Planck-Society
S-(1,2-Dicarboxyethyl)glutathione
C14H21N3O10S (423.09476060000003)
Cefadyl
2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid
2-(4-CARBOXYPHENOXY)-2-PIVALOYL-2,4-DICHLOROACETANILIDE
C20H19Cl2NO5 (423.06402240000006)
Thiazolidine, 3-[(4-methyl-3,5-dinitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
2-CHLORO-4-((3-(2,6-DICHLOROPHENYL)-5-ISOPROPYLISOXAZOL-4-YL)METHOXY)BENZALDEHYDE
C20H16Cl3NO3 (423.01957160000006)
Sodium 4,4-(m-tolylazanediyl)bis(butane-1-sulfonate)
2-Thiophenecarboxamide, 5-chloro-N-[2-hydroxy-3-[[3-methyl-4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]
C19H22ClN3O4S (423.1019482000001)
1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA
C19H13ClF3N3O3 (423.0597494000001)
Prinomastat
C18H21N3O5S2 (423.09225760000004)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate
C19H13ClF3N3O3 (423.0597494000001)
(S)-4-benzyl-3-((2R,3R)-4-chloro-3-(2,4-difluorophenyl)-3-hydroxy-2-methylbutanoyl)oxazolidin-2-one
C21H20ClF2NO4 (423.10488540000006)
potassium 4-[4-[[4-(dimethylamino)phenyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate
C19H18KN3O4S (423.06550480000004)
Pradefovir
C17H19ClN5O4P (423.08631340000005)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
2-[[[4-[(2,6-Dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide
C18H21N3O5S2 (423.09225760000004)
2,2,2-Trifluoro-1-{5-[(3-Phenyl-5,6-Dihydroimidazo[1,2-A]pyrazin-7(8h)-Yl)carbonyl]thiophen-2-Yl}ethane-1,1-Diol
C19H16F3N3O3S (423.0864422000001)
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-2-yl]methoxy]propanoate
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-phenyl-N-sulfooxypropanimidothioate
(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate
2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-(phenylazo)-
[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate
Oxacillin sodium
C19H18N3NaO5S (423.08648180000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z)-4-methylsulfinyl-N-sulfooxybutanimidothioate
Diethyl 2-[[2-(2,4-dichlorophenoxy)anilino]methylidene]propanedioate
C20H19Cl2NO5 (423.06402240000006)
5-bromo-N-[4-[5-(2-methylphenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-furancarboxamide
C20H14BrN3O3 (423.02184740000007)
2-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazole
1-(4-Fluorophenyl)-2-[[4-(2-furanylmethyl)-5-(phenoxymethyl)-1,2,4-triazol-3-yl]thio]ethanone
4-chloro-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide
C18H18ClN3O5S (423.06556480000006)
5-chloro-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-(phenylmethyl)sulfonyl-4-pyrimidinecarboxamide
5-Bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester
C18H22BrN3O4 (423.07935920000006)
(5Z)-2-benzylimino-5-(5-methoxy-3-methyl-1,3-benzothiazol-2-ylidene)-3-prop-2-enyl-1,3-thiazolidin-4-one
methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
C18H18FN3O4S2 (423.07227200000005)
N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide
C21H17N3O3S2 (423.07112920000003)
1-(3-methylphenyl)-3-[(E)-N-(4-methylphenyl)sulfonyl-C-phenylcarbonimidoyl]thiourea
4-[[9-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]benzenesulfonic acid
4-[(2E)-2-[(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)methylidene]hydrazinyl]benzenesulfonamide
2-chloro-N-(2-nitrophenyl)-5-(1-piperidinylsulfonyl)benzamide
C18H18ClN3O5S (423.06556480000006)
N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-2-(4-nitrophenoxy)acetamide
C21H14ClN3O5 (423.06219440000007)
methyl (2E)-2-[(2Z)-2-[1-cyano-2-(furan-2-ylmethylamino)-2-oxoethylidene]-3-(4-methylphenyl)-4-oxo-1,3-thiazolidin-5-ylidene]acetate
C21H17N3O5S (423.08888720000004)
S-(1,2-Dicarboxyethyl)cysteinyl-N-gamma-glutamylglycine
C14H21N3O10S (423.09476060000003)
Cephapirin
A cephalosporin with acetoxymethyl and 2(pyridin-4-ylsulfanyl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. It is used (as its sodium salt) as an antibiotic, being effective against gram-negative and gram-positive organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
PXL770
PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)[1].
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP) (EC50: 1.37?μM for α-casein hydrolysis by HsClpP). ZK53 is is inactive toward bacterial ClpP proteins. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells. ZK53 induces dysregulation of mitochondrial functions in lung squamous cell carcinoma (LUSC) cells. ZK53 inhibits tumor growth in H1703 xenograft mouse model[1].
{3-[5-hydroxy-4-(1h-indol-3-yl)-2-oxopyrrol-3-yl]-1h-indol-6-yl}oxidanesulfonic acid
C20H13N3O6S (423.05250380000007)
(1s)-1-methyl-18-oxa-7λ⁶-thia-10-azahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6(11),14,17(24),19-hexaene-5,7,7,12,16-pentone
C22H17NO6S (423.07765420000004)
n-{[(2r,3s)-2-(3,5-dihydroxy-4-methoxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]methyl}methylsulfanylcarboximidic acid
C19H21NO8S (423.09878260000005)
n-{[2-(3,5-dihydroxy-4-methoxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]methyl}methylsulfanylcarboximidic acid
C19H21NO8S (423.09878260000005)